Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Antidilutive Securities (Details)

v3.22.2
Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 12,987,723 12,935,243 12,987,723 9,938,201
Options to purchase common stock        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 319,585 405,638 319,585 0
Unvested RSUs and PSUs        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 2,299,589 2,161,056 2,299,589 39,652
Warrants        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 470,000 470,000 470,000 0
Convertible Notes        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 9,898,549 9,898,549 9,898,549 9,898,549